Tuesday, September 8, 2009

Salix Receives FDA Marketing Approval for METOZOLV ODT

Sep 8, 2009 - Salix Pharmaceuticals, Ltd. today announced the U.S. FDA has granted marketing approval for METOZOLV™ ODT (metoclopramide HCl) 5mg and 10mg orally disintegrating tablets.

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)